Novartis Ag (NVS) Change in Inventory (2010 - 2025)
Novartis Ag (NVS) posted Change in Inventory of $55.0 million for Q1 2025, up 142.97% sequentially from -$128.0 million in Q1 2024, and up 142.97% YoY from $22.6 million in Q1 2024.
Novartis Ag (NVS) Change in Inventory (2010 - 2025) Analysis & Trends
Novartis Ag (NVS) has 5 years of Change in Inventory data on file, last reported at $55.0 million in Q1 2025.
- Quarterly Change in Inventory rose 142.97% year-over-year to $55.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$1.1 billion (up 4.69% YoY) and the FY2017 annual result came in at $893.0 million, changed N/A from the prior year.
- Change in Inventory rose to $55.0 million in Q1 2025 per NVS's latest filing, from -$128.0 million in the prior quarter.
- The five-year high for Change in Inventory was $55.0 million in Q1 2025, with the low at -$620.0 million in Q1 2023.
- Average Change in Inventory over 4 years is -$279.5 million, with a median of -$276.5 million recorded in 2022.
- Year-over-year, Change in Inventory tumbled 45.88% in 2023 and jumped 142.97% in 2025.
- Novartis Ag's Change in Inventory stood at -$425.0 million in 2022, then tumbled by 45.88% to -$620.0 million in 2023, then soared by 79.35% to -$128.0 million in 2024, then jumped by 142.97% to $55.0 million in 2025.
- Business Quant data shows NVS's Change in Inventory at $55.0 million in Q1 2025, -$128.0 million in Q1 2024, and -$620.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 431.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 184.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | -116.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 55.00 Mn |
| Mar 31, 2025 | 55.00 Mn |
| Mar 31, 2024 | -128.00 Mn |
| Mar 31, 2024 | -128.00 Mn |
| Mar 31, 2023 | -620.00 Mn |
| Mar 31, 2023 | -620.00 Mn |
| Mar 31, 2022 | -425.00 Mn |
| Mar 31, 2022 | -425.00 Mn |
| Dec 31, 2012 | 1.20 Bn |
| Dec 31, 2012 | 1.20 Bn |
| Sep 30, 2012 | 107.00 |
| Sep 30, 2012 | 107.00 |
| Mar 31, 2012 | 15.00 |
| Mar 31, 2012 | 15.00 |
| Dec 31, 2011 | -1.45 Bn |
| Dec 31, 2011 | -1.45 Bn |
| Sep 30, 2011 | -10.00 |
| Sep 30, 2011 | -10.00 |
| Jun 30, 2011 | 239.00 |
| Jun 30, 2011 | 239.00 |